NCT00186316View on ClinicalTrials.gov

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

December 31, 2008

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Idiotype-pulsed allogeneic dendritic cells

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT00186316 - Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells | Biotech Hunter | Biotech Hunter